Sullivan Edward Aloysius Jr. 5
5 · Comera Life Sciences Holdings, Inc. · Filed Feb 14, 2023
Insider Transaction Report
Form 5
Sullivan Edward Aloysius Jr.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-19+44,981→ 44,981 totalExercise: $0.59Exp: 2031-09-16→ Common Stock (44,981 underlying)
Footnotes (2)
- [F1]The shares underlying the option vest in 48 equal monthly installments beginning on September 16, 2021.
- [F2]This option was issued pursuant to the terms of a business combination agreement involving the issuer and Comera Life Sciences, Inc. in exchange for a comparable option previously issued by such company.